(Q34193622)

31 July 2017

1 reference

title

Clinical pharmacokinetics of the third generation cephalosporins (English)

1 reference

31 July 2017

1 reference

L Balant

1

1 reference

31 July 2017

P Dayer

series ordinal

2

1 reference

31 July 2017

R Auckenthaler

series ordinal

3

1 reference

31 July 2017

publication date

1 March 1985

1 reference

Clinical Pharmacokinetics

31 July 2017

published in

1 reference

31 July 2017

volume

10

1 reference

31 July 2017

issue

2

1 reference

31 July 2017

page(s)

101-143

1 reference

https://scigraph.springernature.com/pub.10.2165/00003088-198510020-00001

31 July 2017

exact match

0 references

cites work

Cefotaxime kinetics after intravenous and intramuscular injection of single and multiple doses

1 reference

12 December 2020

The comparative pharmacokinetics of ceftazidime and cefotaxime in healthy volunteers

1 reference

12 December 2020

Pharmacokinetics of ceftazidime in patients with renal insufficiency

1 reference

12 December 2020

Pharmacokinetics of ceftazidime in normal and uremic subjects

1 reference

12 December 2020

Comparative pharmacokinetics of ceftazidime and moxalactam

1 reference

12 December 2020

A review of the penetration of antibiotics into CSF and its clinical significance

1 reference

12 December 2020

Enterococcal Infections in Patients Treated with Moxalactam

1 reference

12 December 2020

Epimers of moxalactam: in vitro comparison of activity and stability

1 reference

12 December 2020

Disulfiram-like Reaction to Certain Cephalosporins

1 reference

12 December 2020

Pharmacokinetics and Clinical Efficacy of Moxalactam in Biliary Tract Infections

1 reference

12 December 2020

Pharmacokinetics and cerebrospinal fluid bactericidal activity of ceftriaxone in the treatment of pediatric patients with bacterial meningitis

1 reference

12 December 2020

Comparative Multiple-Dose Pharmacokinetics of Cefotaxime, Moxalactam, and Ceftazidime

1 reference

12 December 2020

Reports on ceftriaxone (Rocephin)

1 reference

12 December 2020

Cefsulodin pharmacokinetics in patients with various degrees of renal function

1 reference

12 December 2020

Antabuse effect with cephalosporins

1 reference

12 December 2020

Disulfiram-like reaction associated with a parenteral cephalosporin

1 reference

12 December 2020

[Pharmacokinetic study of a cephalosporin, cefoperazone, in liver failure]

1 reference

12 December 2020

Cefotaxime concentrations in ascites

1 reference

12 December 2020

Pharmacokinetics of ceftriaxone in neonates and infants with meningitis

1 reference

12 December 2020

Moxalactam epimer kinetics in children

1 reference

12 December 2020

In Vitro and in Vivo Antibacterial Activity of Moxalactam, an Oxa-β-Lactam Antibiotic

1 reference

12 December 2020

Cefotaxime concentration in cerebrospinal fluid

1 reference

12 December 2020

High-performance liquid chromatographic determination of ceftizoxime, a new cephalosporin antibiotic, in rat serum, bile and urine

1 reference

12 December 2020

Inhibition of vitamin K-dependent carboxylase in vitro by cefamandole and its structural analogs

1 reference

12 December 2020

Comparison of ceftriaxone and traditional therapy of bacterial meningitis

1 reference

12 December 2020

Comparative antipseudomonal activity of some newer beta-lactam agents

1 reference

12 December 2020

Pharmacokinetics of cefotaxime and metabolites in uremic patients (author's transl)

1 reference

12 December 2020

Comparative pharmacokinetics of cefotaxime and ceftizoxime and the role of desacetylcefotaxime in the antibacterial activity of cefotaxime

1 reference

12 December 2020

Cefotaxime concentration in the bile and wall of the gallbladder

1 reference

12 December 2020

Comparative pharmacokinetics of cefoperazone and cefotaxime

1 reference

12 December 2020

Moxalactam pharmacokinetics during hemodialysis

1 reference

12 December 2020

Diarrhoea and annihilation of faecal flora associated with cefpiramide

1 reference

12 December 2020

Comparative In Vitro Activity of New Beta-Lactam Antibiotics Against Anaerobic Bacteria

1 reference

12 December 2020

Pharmacokinetics of intravenous cefotaxime in patients undergoing chronic hemodialysis

1 reference

12 December 2020

Cefsulodin kinetics in healthy subjects after intramuscular and intravenous injection.

1 reference

12 December 2020

Comparative pharmacokinetics of ceftizoxime and other third-generation cephalosporins in humans

1 reference

12 December 2020

Anion-exchange extraction of cephapirin, cefotaxime, and cefoxitin from serum for liquid chromatography

1 reference

12 December 2020

Measurement of serum and tissue concentration of moxalactam using high pressure liquid chromatography

1 reference

12 December 2020

Hepatic clearance of drugs in kidney failure

1 reference

12 December 2020

Comparative pharmacokinetics of cefoperazone, cefotaxime, and moxalactam

1 reference

12 December 2020

Cefoperazone: A review of its in vitro antimicrobial activity, pharmacological properties and therapeutic efficacy

1 reference

12 December 2020

Effect of Broad-Spectrum Cephalosporins on the Microbial Flora of Recipients

1 reference

12 December 2020

Pharmacokinetics of ceftriaxone in patients with renal and liver insufficiency and correlations with a physiologic nonlinear protein binding model

1 reference

12 December 2020

Pharmacokinetics of ceftizoxime in patients undergoing continuous ambulatory peritoneal dialysis

1 reference

12 December 2020

Kinetic interactions between azlocillin, cefotaxime, and cefotaxime metabolites in normal and impaired renal function

1 reference

12 December 2020

HPLC determination of D and L moxalactam in human serum and urine

1 reference

12 December 2020

Moxalactam kinetics during chronic ambulatory peritoneal dialysis

1 reference

12 December 2020

New drugs for enteric gram-negative bacillary meningitis in adults

1 reference

12 December 2020

Pharmacokinetics, protein binding, and predicted extravascular distribution of moxalactam in normal and renal failure subjects

1 reference

12 December 2020

Factors affecting drug metabolism

1 reference

12 December 2020

Plasma vitamin K1 in mothers and their newborn babies

1 reference

12 December 2020

Comparative susceptibilities of Pseudomonas aeruginosa to 1-oxacephalosporin (LY 127935) and eight other antipseudomonal antimicrobial agents (old and new).

1 reference

12 December 2020

The beta-lactamases of gram-negative bacteria and their role in resistance to beta-lactam antibiotics

1 reference

12 December 2020

Absolute Bioavailability of Ceftriaxone after Intramuscular Administration to Healthy Volunteers

1 reference

12 December 2020

Pharmacokinetics of Ceftriaxone in Pediatric Patients With Meningitis

1 reference

12 December 2020

Pharmacokinetics of cefoperazone in patients undergoing chronic ambulatory peritoneal dialysis: clinical and pathophysiological implications

1 reference

12 December 2020

Interaction between moxalactam and alcohol

1 reference

12 December 2020

Pharmacokinetics of ceftizoxime in subjects with various degrees of renal function

1 reference

12 December 2020

Ceftriaxone A Review of its Antibacterial Activity, Pharmacological Properties and Therapeutic Use

1 reference

12 December 2020

Disulfiram-like reaction to a cephalosporin

1 reference

12 December 2020

In vitro activity of moxalactam against anaerobic bacteria

1 reference

12 December 2020

[Pharmacokinetics of ceftizoxime with and without probenecid]

1 reference

12 December 2020

Moxalactam and cefazolin: comparative pharmacokinetics in normal subjects

1 reference

12 December 2020

In vitro antibacterial activity and susceptibility of the cephalosporin Ro 13-9904 to beta-lactamases

1 reference

12 December 2020

Comparison of ceftazidime concentrations in bile and serum

1 reference

12 December 2020

A pharmacokinetic and tolerance study of Ro13-9904, a new cephalosporin antibiotic

1 reference

12 December 2020

Phase I Study of Ceftizoxime, a New Cephalosporin. Repeated Dosing Study

1 reference

12 December 2020

Cefoperazone: pharmacokinetics in humans with normal and impaired renal function and pharmacokinetics in rats

1 reference

12 December 2020

Comparison of cefotaxime and moxalactam pharmacokinetics and tissue levels

1 reference

12 December 2020

beta-Lactam pharmacology in liver disease

1 reference

12 December 2020

Pharmacokinetics of cefotaxime in subjects with normal and impaired renal function

1 reference

12 December 2020

Ceftriaxone pharmacokinetics in patients with various degrees of renal impairment

1 reference

12 December 2020

Cefotaxime kinetics after multiple-dose intramuscular study in healthy volunteers

1 reference

12 December 2020

Single-dose plasma and cerebrospinal fluid pharmacokinetics of ceftriaxone in infants and children

1 reference

12 December 2020

Elimination Kinetics of Cefotaxime and Desacetyl Cefotaxime in Patients with Renal Insufficiency and during Hemodialysis

1 reference

12 December 2020

The third generation cephalosporins: panacea or Pandora's Box

1 reference

12 December 2020

Cefotaxime: pharmacokinetics and in vitro antibacterial activity of serum and urine in normal human volunteers

1 reference

12 December 2020

Pharmacokinetics of ceftriaxone in patients with renal failure and in those undergoing hemodialysis

1 reference

12 December 2020

Pharmacokinetics of ceftizoxime

1 reference

12 December 2020

The classification and terminology of enzymes that hydrolyze beta-lactam antibiotics

1 reference

12 December 2020

Human pharmacology of cefotaxime (HR 756), a new cephalosporin

1 reference

12 December 2020

Human metabolism of cefotaxime

1 reference

12 December 2020

Ro 13-9904, a long-acting broad-spectrum cephalosporin: in vitro and in vivo studies

1 reference

12 December 2020

Effects of Moxalactam on Blood Coagulation and Platelet function

1 reference

12 December 2020

Multiple intravenous dose pharmacokinetics of ceftriaxone in man

1 reference

12 December 2020

Pharmacokinetics and bacteriological effect of ceftazidime in experimental Streptococcus pneumoniae, Haemophilus influenzae, and Escherichia coli meningitis

1 reference

12 December 2020

On the pharmacokinetics of latamoxef in normal and impaired renal function.

1 reference

12 December 2020

Intestinal side effects of cefoperazone

1 reference

12 December 2020

Multiple-dose pharmacokinetics of ceftazidime in cancer patients

1 reference

12 December 2020

Age and ceftriaxone kinetics

1 reference

12 December 2020

Determination of ceftazidime in biological fluids by using high-pressure liquid chromatography

1 reference

12 December 2020

Pharmacokinetics of Cephalosporin Antibiotics

1 reference

12 December 2020

Moxalactam (Latamoxef) A Review of its Antibacterial Activity, Pharmacokinetic Properties and Therapeutic Use

1 reference

12 December 2020

Moxalactam kinetics in hemodialysis

1 reference

12 December 2020

Cefoperazone in Klebsiella meningitis: a case report

1 reference

12 December 2020

Penetration of ceftazidime into extracellular fluid in patients

1 reference

12 December 2020

Steady-state moxalactam kinetics: comparisons with other cephalosporins

1 reference

12 December 2020

Penetration of ceftazidime into the cerebrospinal fluid of patients with and without evidence of meningeal inflammation

1 reference

12 December 2020

Effect of Ceftizoxime, a New Cephalosporin Antibiotic, on Binding of Bilirubin to Human Serum Albumin

1 reference

12 December 2020

Pharmacologic basis for antimicrobial therapy of neonatal meningitis

1 reference

12 December 2020

Diffusion of a new beta-lactam (LY 127935) into cerebrospinal fluid. Implications for therapy of gram-negative bacillary meningitis

1 reference

12 December 2020

Pharmacokinetics of single intravenous and intramuscular doses of cefotetan in normal human volunteers

1 reference

12 December 2020

Metabolism of cefotaxime: a review

1 reference

12 December 2020

Activity of the cefotaxime (HR756) desacetyl metabolite compared with those of cefotaxime and other cephalosporins

1 reference

12 December 2020

Differences in kinetic properties of drugs: implications as to the selection of a particular drug for use in patients with renal failure with special emphasis on antibiotics and beta-adrenoceptor blocking agents

1 reference

12 December 2020

Past and current roles for cephalosporin antibiotics in treatment of meningitis. Emphasis on use in gram-negative bacillary meningitis

1 reference

12 December 2020

Cefotetan elimination in patients with varying degrees of renal dysfunction

1 reference

12 December 2020

Pharmacokinetic characteristics of intravenous ceftriaxone in normal adults

1 reference

12 December 2020

Pharmacokinetics of cefoperazone in normal subjects and patients with hepatosplenic schistosomiasis

1 reference

12 December 2020

Ceftizoxime and other third-generation cephalosporins: structure-activity relationships

1 reference

12 December 2020

Pharmacokinetics of moxalactam in neonates and young infants

1 reference

12 December 2020

Activities of New Beta-Lactam Antibiotics Against Isolates of Pseudomonas aeruginosa from Patients with Cystic Fibrosis

1 reference

12 December 2020

Biliary excretion and pharmacokinetics of cefoperazone in humans

1 reference

12 December 2020

A review and summary of the pharmacokinetics of cefoperazone: a new, extended-spectrum beta-lactam antibiotic

1 reference

12 December 2020

Pharmacokinetics of a new cephalosporin, cefoperazone

1 reference

12 December 2020

Susceptibility of pneumococci to 14 beta-lactam agents: comparison of strains resistant, intermediate-resistant, and susceptible to penicillin

1 reference

12 December 2020

Pharmacokinetics of cefoperazone, moxalactam, cefotaxime, trimethoprim and suiphamethoxazole in experimental meningitis

1 reference

12 December 2020

Comparison of the β-lactamase stability and the in-vitro activity of cefoperazone, cefotaxime, cefsulodin, ceftazidime, moxalactam and ceftriaxone against Pseudomonas aeruginosa

1 reference

12 December 2020

Description and classification of the newer cephalosporins and their relationships with the established compounds

1 reference

12 December 2020

High performance liquid chromatographic assay of cefsulodin, cefotiam and cefmenoxime in serum and urine

1 reference

12 December 2020

Affinities of penicillins and cephalosporins for the penicillin-binding proteins of Escherichia coli K-12 and their antibacterial activity

1 reference

12 December 2020

Cefotaxime pharmacokinetics following a single intravenous dose to patients with varying renal function

1 reference

12 December 2020

Cefoperazone: absorption, excretion, distribution, and metabolism

1 reference

12 December 2020

Single-dose pharmacokinetics of cefoperazone following intravenous administration

1 reference

12 December 2020

Volume of distribution terms for a drug (ceftriaxone) exhibiting concentration-dependent protein binding. I. Theoretical considerations.

1 reference

12 December 2020

Pharmacokinetics of ceftizoxime in patients undergoing hemodialysis

1 reference

12 December 2020

Interaction between cephalosporins and alcohol

1 reference

12 December 2020

Comparison of the concentrations of ceftazidime in the serum of newborn infants after intravenous and intramuscular administration

1 reference

12 December 2020

Adverse effects of third-generation cephalosporins.

1 reference

12 December 2020

Penicillins and cephalosporins: antimicrobial and pharmacological properties

1 reference

12 December 2020

Kinetic disposition of intravenous ceftriaxone in normal subjects and patients with renal failure on hemodialysis or peritoneal dialysis

1 reference

12 December 2020

Pharmacokinetics and cerebrospinal fluid penetration of moxalactam in children with bacterial meningitis

1 reference

12 December 2020

Diffusion of ceftriaxone (Ro 13-9004/001) in the cerebrospinal fluid. Comparison with other beta-lactam antibiotics in dogs with healthy meninges and in dogs with experimental meningitis

1 reference

12 December 2020

In Vitro Antibacterial Activity and β-Lactamase Stability of SCE-129, a New Cephalosporin

1 reference

12 December 2020

The new beta-lactamase-stable cephalosporins

1 reference

12 December 2020

An evaluation of the activity of cephalosporins against Pseudomonas aeruginosa

1 reference

12 December 2020

Comparative Activity and β-Lactamase Stability of Cefoperazone, a Piperazine Cephalosporin

1 reference

12 December 2020

In-vitro susceptibility of Pseudomonas aeruginosa to old and new beta-lactam antibiotics and aminoglycosides

1 reference

12 December 2020

Determination of cefsulodin, cefotiam, cephalexin, cefotaxime, desacetyl-cefotaxime, cefuroxime and cefroxadin in plasma and urine by high-performance liquid chromatography

1 reference

12 December 2020

Decreased extrarenal clearance of cefoperazone in hepatocellular diseases

1 reference

12 December 2020

Pharmacokinetics of moxalactam in patients with renal insufficiency

1 reference

12 December 2020

Phase I study of ceftizoxime, a new cephalosporin. Single-dose study

1 reference

12 December 2020

Determination of cefoperazone concentration in serum and muscle tissue with a versatile high-pressure liquid chromatographic method

1 reference

12 December 2020

Pharmacokinetics of ceftazidime in male and female volunteers

1 reference

12 December 2020

Pharmacokinetics of cefotaxime in patients with chronic renal impairment (author's transl)

1 reference

12 December 2020

Pharmacokinetics of moxalactam in subjects with various degrees of renal dysfunction

1 reference

12 December 2020

Ceftriaxone: renal and biliary excretion and effect on the colon microflora

1 reference

12 December 2020

Crossover study of the pharmacokinetics of ceftriaxone administered intravenously or intramuscularly to healthy volunteers

1 reference

12 December 2020

Antibacterial activity of ceftriaxone (Ro 13-9904), a beta-lactamase-stable cephalosporin

1 reference

12 December 2020

Potential value of cefoperazone in bacterial meningitis: experimental studies

1 reference

12 December 2020

Single-dose ceftriaxone kinetics in functionally anephric patients

1 reference

12 December 2020

High-pressure liquid chromatographic assay of ceftizoxime with an anion-exchange extraction technique

1 reference

12 December 2020

Steady-state moxalactam pharmacokinetics in patients: noncompartmental versus two-compartmental analysis

1 reference

12 December 2020

Elimination kinetics of cefotaxime in patients with renal insufficiency requiring dialysis

1 reference

12 December 2020

Effect of protein binding on simulated intravascular and extravascular kinetics of cefotaxime in an in vitro model

1 reference

12 December 2020

Pharmacokinetics of ceftriaxone following intravenous administration of a 3 g dose

1 reference

12 December 2020

Ceftriaxone: therapeutic results in various infections and kinetic studies

1 reference

12 December 2020

Pharmacokinetics of ceftazidime in normal and impaired renal function

1 reference

12 December 2020

Plasma Protein Binding and Urinary Excretion of R- and S-Epimers of an Arylmalonylamino 1-Oxacephem II: In Rats

1 reference

12 December 2020

Concentrations of cefotaxime and the desacetyl metabolite in serum and CSF of patients with meningitis

1 reference

12 December 2020

Pharmacokinetics of cefotaxime in neonates

1 reference

12 December 2020

In vitro evaluation of cefoperazone

1 reference

12 December 2020

The pharmacokinetics and tissue penetration of ceftazidime and cefamandole in healthy volunteers.

1 reference

12 December 2020

Synergy between cefotaxime, cefsulodin, azlocillin, mezlocillin and amino-glycosides against carbenicillin resistant or sensitive Pseudomonas aeruginosa

1 reference

12 December 2020

Penetration of ceftazidime into cerebrospinal fluid of patients with bacterial meningitis

1 reference

12 December 2020

Clinical Pharmacokinetics of Cefotaxime in Patients with Normal and Reduced Renal Function

1 reference

12 December 2020

Hypoprothrombinemia and platelet dysfunction caused by cephalosporin and oxalactam antibiotics

1 reference

12 December 2020

Cefotaxime Levels in Ventricular Cerebrospinal Fluid, Determined by Bioassay and by High-Performance Liquid Chromatography

1 reference

12 December 2020

Comparative in vitro activity of ceftriaxone against anaerobic bacteria

1 reference

12 December 2020

Hypoprothrombinaemia and cephalosporins

1 reference

12 December 2020

On the disulfiram-like activity of moxalactam

1 reference

12 December 2020

Concepts basic to pharmacokinetics

1 reference

12 December 2020

Pharmacokinetics of cefotaxime in newborn infants

1 reference

12 December 2020

High-pressure liquid chromatography for quantitation of antimicrobial agents

1 reference

12 December 2020

Metabolism of Cefotaxime in Animals and Humans

1 reference

12 December 2020

HR 756, a New Cephalosporin Active Against Gram-Positive and Gram-Negative Aerobic and Anaerobic Bacteria

1 reference

12 December 2020

Host defense and antimicrobial therapy in adult gram-negative bacillary meningitis

1 reference

12 December 2020

Multiple-dose pharmacokinetics of ceftazidime and its influence on fecal flora

1 reference

12 December 2020

Pharmacokinetics of moxalactam and cefazolin compared in normal volunteers

1 reference

12 December 2020

Cefoperazone pharmacokinetics in acute childhood meningitis.

1 reference

12 December 2020

The pharmacokinetics of cefotetan excretion in the unobstructed biliary tree

1 reference

12 December 2020

Cefotaxime A review of its Antibacterial Activity, Pharmacological Properties and Therapeutic Use

1 reference

12 December 2020

Ceftizoxime kinetics and renal handling

1 reference

12 December 2020

The beta-lactamase stability of a novel beta-lactam antibiotic containing a 7 alpha-methoxyoxacephem nucleus

1 reference

12 December 2020

Ceftizoxime elimination kinetics in continuous ambulatory peritoneal dialysis

1 reference

12 December 2020

Distribution of ceftazidime in ascitic fluid

1 reference

12 December 2020

Treatment of Gram-Negative Bacillary Meningitis: Role of the New Cephalosporin Antibiotics

1 reference

12 December 2020

Concentrations of cefoperazone in cerebrospinal fluid during bacterial meningitis

1 reference

12 December 2020

Combination of ceftizoxime with azlocillin, mezlocillin, piperacillin and ticarcillin

1 reference

12 December 2020

Treatment of severe neonatal infections with cefotaxime. Efficacy and pharmacokinetics

1 reference

12 December 2020

Intraperitoneal and intravenous cefoperazone kinetics during continuous ambulatory peritoneal dialysis

1 reference

12 December 2020

Human cerebrospinal fluid pharmacokinetics and treatment of bacterial meningitis with ceftizoxime

1 reference

12 December 2020

Cefoperazone in the treatment of severe or complicated infections

1 reference

12 December 2020

The cephalosporins: activity and clinical use.

1 reference

12 December 2020

Pharmacokinetics of moxalactam in elderly subjects

1 reference

12 December 2020

Pharmacokinetics and tolerance of a 24-h infusion of cefotetan disodium (with and without loading dose) in normal Caucasian volunteers

1 reference

12 December 2020

Clinical pharmacology of moxalactam in patients with malignant disease

1 reference

12 December 2020

Ceftizoxime. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

1 reference

12 December 2020

Carboxylated calcium-binding proteins and vitamin K.

1 reference

12 December 2020

Human pharmacology and tissue levels of CGP 7174/E: a new antipseudomonal cephalosporin

1 reference

12 December 2020

Cefoperazone (Cefobid, Pfizer)

1 reference

12 December 2020

In vitro activity of cefotetan, a new cephamycin derivative, compared with that of other beta-lactam compounds

1 reference

12 December 2020

The Pharmacokinetics of Cefotaxime and Its Metabolites in Subjects with Normal and Impaired Renal Function

1 reference

12 December 2020

Moxalactam (LY127935) in treatment of meningitis due to gram-negative bacilli

1 reference

12 December 2020

Clinical evaluation of moxalactam: evidence of decreased efficacy in gram-positive aerobic infections

1 reference

12 December 2020

A comparative evaluation of moxalactam: antimicrobial activity, pharmacokinetics, adverse reactions, and clinical efficacy

1 reference

12 December 2020

Metabolism of cefotaxime in animals and man

1 reference

12 December 2020

Ceftriaxone diffusion into cerebrospinal fluid of children with meningitis

1 reference

12 December 2020

Pharmacokinetics of cefotaxime in normal human volunteers

1 reference

12 December 2020

Tissue penetration characteristics of ceftizoxime and cefazolin in human bile and gallbladder wall

1 reference

12 December 2020

Cefotaxime and desacetyl cefotaxime in human bile

1 reference

12 December 2020

Pharmacokinetics of ceftriaxone in humans

1 reference

12 December 2020

Antimicrobial activity, pharmacokinetics, adverse reactions, and therapeutic indications of cefoperazone

1 reference

12 December 2020

Precise high-performance liquid chromatographic procedure for the determination of cefsulodin, a new antipseudomonal cephalosporin antibiotic, in plasma

1 reference

12 December 2020

Plasma Protein Binding and Urinary Excretion of R- and S-Epimers of an Arylmalonylamino 1-Oxacephem I: In Humans

1 reference

12 December 2020

Inducible beta-lactamases and non-hydrolytic resistance mechanisms

1 reference

12 December 2020

Pharmacokinetics of ceftazidime in renal failure

1 reference

12 December 2020

Pharmacokinetics of ceftazidime in normal subjects

1 reference

12 December 2020

Antibiotic pharmacokinetics and clinical application in renal insufficiency.

1 reference

12 December 2020

The tissue penetration, as measured by a blister technique, and pharmacokinetics of cefsulodin compared with carbenicillin and ticarcillin.

1 reference

12 December 2020

How many cephalosporins does the clinician need?

1 reference

12 December 2020

Clinical use of the new beta-lactam antimicrobial drugs. Practical considerations for physicians, microbiology laboratories, pharmacists, and formulary committees

1 reference

12 December 2020

Mechanism of Action, Antimicrobial Activity, Pharmacology, Adverse Effects, and Clinical Efficacy of Cefotaxime

1 reference

12 December 2020

Empiric therapy for bacterial infections. Evaluation of cefoperazone. A symposium. Geneva, Switzerland October 4-5, 1981

1 reference

12 December 2020

The pharmacokinetic behaviour of ceftazidime in man and the relationship between serum levels and the in vitro susceptibility of clinical isolates

1 reference

12 December 2020

Liquid chromatographic assay of ceftizoxime in sera of normal and uremic patients

1 reference

12 December 2020

Assay of ceftazidime in biological fluids using high-pressure liquid chromatography.

1 reference

12 December 2020

Effect of Altered Plasma Protein Binding on Apparent Volume of Distribution

1 reference

12 December 2020

Effects of concentration-dependent plasma protein binding on ceftriaxone kinetics.

1 reference

12 December 2020

Biliary Excretion of Ceftizoxime in Humans

1 reference

12 December 2020

Pharmacokinetics and tolerance of single intravenous doses of cefotetan disodium in male Caucasian volunteers

1 reference

12 December 2020

Prolonged Bleeding Times and Bleeding Diathesis Associated With Moxalactam Administration

1 reference

12 December 2020

Determination of ceftriaxone, a novel cephalosporin, in plasma, urine and saliva by high-performance liquid chromatography on an NH2 bonded-phase column

1 reference

12 December 2020

Determination of cefsulodin in biological fluids by high-pressure liquid chromatography

1 reference

12 December 2020

Pharmacokinetics of cefotaxime and desacetyl-cefotaxime in cirrhosis of the liver

1 reference

12 December 2020

Pharmacokinetics of moxalactam in subjects with normal and impaired renal function

1 reference

12 December 2020

Antibacteroides and β-lactamase inhibitory activities of moxalactam

1 reference

12 December 2020

Ceftizoxime: a beta-lactamase-stable, broad-spectrum cephalosporin. Pharmacokinetics, adverse effects and clinical use.

1 reference

12 December 2020

Serum and urine concentrations of cefoperazone in severe chronic renal failure

1 reference

12 December 2020

Cefotaxime metabolism and renal function

1 reference

12 December 2020

Volume of distribution terms for a drug (ceftriaxone) exhibiting concentration-dependent protein binding. II. Physiological significance.

1 reference

12 December 2020

Pharmacokinetic study of a cephalosporin: cefoperazone in patients with a Kehr drain

1 reference

12 December 2020

Renal Excretion of R-and S-Epimers of Moxalactam in Dogs

1 reference

12 December 2020

Pharmacokinetics of moxalactam in adults

1 reference

12 December 2020

From penicillin-binding proteins to the lysis and death of bacteria: a 1979 view

1 reference

12 December 2020

The use of ceftizoxime in the treatment of critically ill patients infected with multiply antibiotic resistant bacteria.

1 reference

12 December 2020

Mechanisms of Bacterial Resistance to Antimicrobial Agents, with Particular Reference to Cefotaxime and Other β-Lactam Compounds

1 reference

12 December 2020

Pharmacokinetics and tolerance of single intramuscular doses of cefotetan in normal Caucasian volunteers

1 reference

12 December 2020

Pharmacokinetics and efficacy of ceftazidime in experimental Haemophilus influenzae b meningitis.

1 reference

12 December 2020

Enterococcal superinfection and colonization after therapy with moxalactam, a new broad-spectrum antibiotic.

1 reference

12 December 2020

Pharmacokinetics of ceftazidime in premature, newborn and young infants

1 reference

12 December 2020

Pharmacokinetics of Rocephin, a highly active new cephalosporin with an exceptionally long biological half-life

1 reference

12 December 2020

Pharmacokinetics of cefotaxime

1 reference

12 December 2020

Cefsulodin kinetics in renal impairment

1 reference

12 December 2020

Pharmacokinetics and Bacteriologic Efficacy of Moxalactam, Cefotaxime, Cefoperazone, and Rocephin in Experimental Bacterial Meningitis

1 reference

12 December 2020

Comparison of cefoperazone with penicillin, ampicillin, gentamicin, and chloramphenicol in the therapy of experimental meningitis

1 reference

12 December 2020

Pharmacology of cefotaxime and its desacetyl metabolite in renal and hepatic disease

1 reference

12 December 2020

Cefotaxime: A Review of in Vitro Antimicrobial Properties and Spectrum of Activity

1 reference

12 December 2020

Pharmacokinetic studies of ceftazidime in serum, bone, bile, tissue fluid and peritoneal fluid

1 reference

12 December 2020

Pharmacology of a new 1-oxa-beta-lactam (LY127935) in normal volunteers

1 reference

12 December 2020

Kinetics of cefotaxime in healthy subjects (author's transl)

1 reference

12 December 2020

Effect of decreased renal function on the pharmacokinetics of ceftazidime

1 reference

12 December 2020

The pharmacy of ceftazidime.

1 reference

12 December 2020

10.2165/00003088-198510020-00001

Identifiers

DOI

1 reference

Dimensions Publication ID

31 July 2017

1003904402

0 references

1 reference